The risk of bleeding after percutaneous liver biopsy: relation to platelet count

J Clin Gastroenterol. 1982 Oct;4(5):451-3. doi: 10.1097/00004836-198210000-00011.

Abstract

We sought to define the risk of bleeding after percutaneous aspiration liver biopsy in patients with low platelet counts but otherwise normal clotting factors. Eighty-seven patients underwent liver biopsy using the Menghini 1-second technique with either a 1.6-mm or a 1.2-mm needle. Bleeding occurred in three out of 13 patients whose platelet counts at the time of biopsy were 60,000/mm3 or less, as compared to no bleeding in 74 patients with higher platelet counts (p = 0.003). A liver biopsy should not necessarily be withheld because of low platelet counts unless they are below 60,000/mm3 and cannot be raised for an adequate time during and after biopsy.

Publication types

  • Case Reports
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Anemia, Aplastic / complications
  • Biopsy, Needle / adverse effects*
  • Child
  • Female
  • Hemorrhage / etiology*
  • Humans
  • Leukemia, Lymphoid / complications
  • Liver / pathology*
  • Male
  • Needles
  • Platelet Count*
  • Risk